Startup profile · funding coverage
Alleviate Health funding, valuation and investors
AI recruiter automating patient enrollment for clinical research sites.
Keep track of Alleviate Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$4.3M · October 2025
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$4.3M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Durham, NC
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Alleviate Health provides an AI-powered recruitment platform for clinical research sites. Its human-in-the-loop agents engage potential trial participants 24/7 via SMS and voice, screen against protocol eligibility, schedule visits, and escalate to human recruiters when needed. The product includes a clinical-research-specific CRM that captures patient preferences and interaction history. Founded in 2023 and headquartered in Durham, North Carolina, Alleviate publicly launched in October 2025 after raising a $4.3M seed round led by Andreessen Horowitz. The company reports working with seven of the top 15 U.S. site networks and handling 500,000+ patient interactions across 190+ sites and 300+ trials in its first year of operations.
Why Alleviate Health is interesting
Human-in-the-loop SMS and voice agents already run at 190+ sites — Alleviate attacks the site-level recruitment bottleneck that delays trials, not sponsor-side ad spend.
Product & use cases
Alleviate deploys SMS and voice AI agents that pre-screen trial candidates, book on-site visits, and hand off qualified leads to site recruiters — integrated with CTMS/CRM systems sites already use.
- High-volume outbound patient outreach for multi-site trial recruitment
- Protocol-based pre-screening via SMS before CRC visits
- Voice-AI pre-qualification with warm transfer to human recruiters
Key facts
- Seed (Oct 2025): $4.3M led by a16z (Business Wire)
- Live at 190+ sites in U.S. and Canada; 500k+ patient interactions in first year
- Customers include Alcanza, CenExel, M3 Wake, Centricity, Eximia among top site networks
- Co-investors not in VCT directory: Alt Capital, First Harmonic
Funding history (newest first)
Investors in our directory
Funds linked from Alleviate Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Site-network distribution (7 of top 15 U.S. networks) and 500k+ interaction training data give Alleviate workflow depth across indications vs. generic conversational AI tools.
Clinical trial recruitment splits between sponsor-side patient finding (EHR analytics, DTC ads) and site-level operational bottlenecks. Alleviate targets the latter — where coordinators manually call thousands of leads — with agents trained across 300+ trials. Competitors like Antidote and StudyPages focus more on patient discovery and marketing. Site networks' willingness to adopt human-in-the-loop AI (vs. full replacement) is the product bet; early scale across top networks is the traction signal.
-
Antidote direct
Patient-matching and recruitment marketing for trials; Alleviate focuses on site-operational workflows and CRM integration.
-
Deep 6 AI adjacent
EHR-based patient finding for health systems; Alleviate targets site recruiter operations and outbound engagement.
-
TrialSpark / similar CRO tools adjacent
Full-service and hybrid models; Alleviate sells software agents to existing site staff.
-
Manual site recruiter teams incumbent
Default approach — phone tag and fragmented systems; Alleviate automates repetitive pre-screening while keeping humans for conversion.
Notable stories
- Alleviate taped customer feedback from recruiter Haley McSweeney on its office wall — she said AI removes pre-screening drudgery but won't replace human connection needed for trial enrollment (company LinkedIn launch post).
- The a16z deal was a collaboration between Apps and Bio/Health teams per partner Marc Andrusko — reflecting cross-practice interest in vertical AI agents.
- Founders built the product while embedded with site networks, optimizing messaging across 'every possible patient population, indication, and workflow' before public launch.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Alleviate Health's financing or category context.
FAQs about Alleviate Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.